Measuring Glucose Uptake
Glucose metabolism is a key process in many organisms. A lack of insulin-stimulated glucose uptake is associated with type 2 diabetes, while high glucose uptake is a sign of the high glycolytic rates associated with cancer. Measuring glucose uptake can determine the effects of various treatments for diabetes and cancer.
The gold standard method of assaying glucose uptake relies on detection of radio-labeled glucose analogs. Alternative colorimetric and fluorometric glucose uptake assays often lack the sensitivity and robustness needed to reliably measure glucose uptake in cells.
シンプルでNon-RI のグルコース取込みアッセイ
Glucose Uptake-Glo™ Assay は細胞でのグルコース取込みを発光法により測定するプレートベースのホモジニアスアッセイで、2-deoxyglucose-6-phosphate (2DG6P) の検出がベースになっています。
"Promega products are reliable and can be purchased without any hesitation. My experiment went very well as expected and we have more plans to conduct uptake experiments using the Glucose Uptake-Glo™ Assay."
Glucose Uptake-Glo と従来のRI 法との比較
2-デオキシグルコース (2DG) を細胞に添加するとグルコースと同様に細胞膜を透過し、迅速にリン酸化され、2-deoxyglucose-6-phosphate (2DG6P) を生成します。Stop Buffer を加えると2DGの輸送が停止し、細胞を溶解し、細胞内に残存するNADPHを破壊してタンパク質を不活性化します。Neutralization Buffer を添加すると 2DG6P Detection Reagent 添加前の溶液が中和されます。試薬に含まれる glucose-6-phosphate dehydrogenase (G6PDH) は 2DG6P を酸化して6-phosphodeoxygluconate (6PDG) を生じ、NADP+を還元してNADPHにします。レダクターゼはNADPHを用いてルシフェリン前駆体から発光酵素ルシフェラーゼの基質ルシフェリンに変換します。
がんおよび脂肪細胞株における代謝変化の測定
MCF7 がん細胞
がんモデルでは細胞が酸素不足になると、この低酸素条件により細胞内代謝が酸化的リン酸化から解糖系にシフトします。この結果としてグルコースの取込みが増加します。
MCF7 cells grown under hypoxia (1% oxygen) show an increase in Glucose Uptake-Glo™, indicating an increased glycolytic rate. The same cells demonstrate no significant change in viability using the RealTime-Glo™ and CellTiter-Fluor™ Assays.
脂肪細胞
脂肪細胞モデルを用いて、3T3L1-MBX 脂肪細胞のグルコース取込み量の変化が細胞健全性に対して顕著な影響を与えなかったことを示しました。Glucose Uptake-Glo™ Assay と RealTime-Glo™ Assay のマルチアッセイにより細胞健全性に対する影響とグルコース取込み変化をすぐに分離して測定することができた。
Results of the Glucose Uptake-Glo™ Assay when adipocyte cells are treated under various conditions, where "None" indicates the basal level of glucose uptake. Insulin induces translocation of glucose transporters to the cell surface, and thus increases glucose uptake above basal levels. Cytochalasin B is a glucose transporter inhibitor which decreases glucose uptake. LY294002, a phosphatidylinositol 3-kinase (PI3K) inhibitor, is an essential insulin signaling enzyme which decreases glucose uptake relative to insulin alone.
Results of the RealTime-Glo™ Assay when adipocyte cells are treated under various conditions, where "None" indicates the basal level of glucose uptake. Although there are dramatic changes in glucose uptake, as seen in the accompanying panel, there are minimal changes in viability as measured by the RealTime-Glo™ Assay.
FAQs
Have questions about this assay? Check our frequently asked questions to find answers.
Protocols
Complete Protocol
Specifications
Catalog Number:
選択製品の構成品内容
| Item | Part # | Size |
|---|---|---|
Luciferase Reagent |
J151A | 1 × 5ml |
Stop Buffer |
J152A | 1 × 15ml |
Neutralization Buffer |
J153A | 1 × 15ml |
NADP+ |
J154A | 1 × 50μl |
G6PDH |
J155A | 1 × 125μl |
2DG |
J156A | 1 × 250μl |
2DG6P Standard |
J157A | 1 × 50μl |
Reductase |
G884C | 1 × 25μl |
Reductase Substrate |
G885A | 1 × 55μl |
U.S. Pat. Nos. 9,273,343 and 9,951,372, European Pat. No. 2751089, Japanese Pat. No. 6067019 and other patents pending.
選択製品の構成品内容
| Item | Part # | Size | Concentration |
|---|---|---|---|
Luciferase Reagent |
J151B | 1 × 10ml | |
Stop Buffer |
J152A | 1 × 15ml | |
Neutralization Buffer |
J153A | 1 × 15ml | |
NADP+ |
J154B | 1 × 100μl | |
G6PDH |
J155B | 1 × 250μl | |
2DG |
J156A | 1 × 250μl | |
2DG6P Standard |
J157A | 1 × 50μl | |
Reductase |
G884A | 1 × 55μl | 6mg/ml |
Reductase Substrate |
G885A | 1 × 55μl |
U.S. Pat. Nos. 9,273,343 and 9,951,372, European Pat. No. 2751089, Japanese Pat. No. 6067019 and other patents pending.
選択製品の構成品内容
| Item | Part # | Size | Concentration |
|---|---|---|---|
Luciferase Reagent |
J151C | 1 × 50ml | |
Stop Buffer |
J152A | 1 × 15ml | |
Neutralization Buffer |
J153A | 1 × 15ml | |
NADP+ |
J154C | 1 × 500μl | |
G6PDH |
J155C | 1 × 1.25ml | |
2DG |
J156A | 1 × 250μl | |
2DG6P Standard |
J157A | 1 × 50μl | |
Reductase |
G884B | 1 × 275μl | 6mg/ml |
Reductase Substrate |
G885A | 1 × 55μl |
U.S. Pat. Nos. 9,273,343 and 9,951,372, European Pat. No. 2751089, Japanese Pat. No. 6067019 and other patents pending.
Related Products
類似製品
Lactate-Glo™ Assay
様々なサンプル種より迅速に乳酸を検出する発光アッセイ
J5021, J5022
Triglyceride-Glo™ Assay
リパーゼによる酵素反応で放出されるグリセロールの測定によりトリグリセリドを検出
J3160, J3161
Lumit® Glucagon Immunoassay
迅速かつ簡単な洗浄不要プロトコルを用いて、細胞培養液や膵島分泌サンプル中のグルカゴンを定量的に測定
W8020, W8022
Lumit® Insulin Immunoassay
Quantitatively measures insulin from cell culture or islet secretion samples using a fast, easy no-wash protocol.
W8010, W8012
関連製品
GloMax® Discover System
発光・蛍光・吸光度測定に対応した高性能マイクロプレートリーダー
GM3000
ROS-Glo™ H2O2 Assay
培養細胞や酵素反応中の過酸化水素レベルを直接測定できる高感度な発光アッセイ
G8820, G8821
GSH/GSSG-Glo™ Assay
培養細胞中の総グルタチオン(GSH +GSSG)、GSSG または GSH/GSSG 比を測定するための発光アッセイ
V6611, V6612
Mitochondrial ToxGlo™ Assay
生体異物への暴露によるミトコンドリア機能障害を予測するためのアッセイ
G8000, G8001